Your search returned 43 studies:
- Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
Conditions: Leukemia
Location: Green Bay, Wisconsin
- Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphob
Conditions: Kidney Cancer - Leukemia - Lymphoma - Neurotoxicity - Peripheral Neuropathy - Sarcoma
Location: Green Bay, Wisconsin
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Neurotoxicity - Psychosocial Effects of Cancer and Its Treatment
Location: Green Bay, Wisconsin
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Conditions: Brain and Central Nervous System Tumors - Chronic Myeloproliferative Disorders - Leukemia - Long-term Effects Secondary to Cancer Therapy in Children - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic S
Location: Green Bay, Wisconsin
- Study of Blood Samples From Newborns With Down Syndrome
Conditions: Leukemia
Location: Green Bay, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuk
Conditions: Leukemia
Location: Green Bay, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuk
Conditions: Leukemia
Location: Manitowoc, Wisconsin
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leuk
Conditions: Leukemia
Location: Marinette, Wisconsin
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Green Bay, Wisconsin
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Green Bay, Wisconsin
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Green Bay, Wisconsin
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Green Bay, Wisconsin
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Manitowoc, Wisconsin
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Marinette, Wisconsin
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Oconto Falls, Wisconsin
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Sturgeon Bay, Wisconsin
- Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Green Bay, Wisconsin
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: Leukemia - Lymphoma
Location: Green Bay, Wisconsin
- Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
Conditions: Leukemia - Lymphoma
Location: Green Bay, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Green Bay, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Manitowoc, Wisconsin
- Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial
Conditions: Leukemia - Lymphoma
Location: Marinette, Wisconsin
- Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
Conditions: Leukemia - Neoplasm of Uncertain Malignant Potential - Unspecified Childhood Solid Tumor, Protocol Specific
Location: Green Bay, Wisconsin
- Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Conditions: Chronic Lymphocytic Leukemia
Location: Green Bay, Wisconsin
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Green Bay, Wisconsin
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
Location: Green Bay, Wisconsin
- Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Green Bay, Wisconsin
- Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
Conditions: Fungal Infection - Leukemia - Neutropenia
Location: Green Bay, Wisconsin
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Conditions: Cognitive/Functional Effects - Leukemia - Neurotoxicity - Pain - Therapy-related Toxicity
Location: Green Bay, Wisconsin
- Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
Conditions: Leukemia, Pediatric
Location: Green Bay, Wisconsin
- Study Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission
Conditions: Leukemia
Location: Green Bay, Wisconsin
- Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
Conditions: Leukemia - Lymphoma
Location: Green Bay, Wisconsin
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Green Bay, Wisconsin
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
Conditions: Contiguous Stage II Adult Lymphoblastic Lymphoma - Noncontiguous Stage II Adult Lymphoblastic Lymphoma - Stage II Adult T-cell Leukemia/Lymphoma - Stage II Childhood Lymphoblastic Lymphoma - Stage III Adult Lymphoblastic Lymphoma - Stage III Adult T-cell
Location: Green Bay, Wisconsin
- Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
Conditions: Adult Acute Erythroid Leukemia (M6) - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Minimally Differentiated Myeloid Leukemia (M0) - Adult Acute Monoblastic Leukemia (M5a) - Adult Acute Monocytic Leukemia (M5b) - Adult Acute Myeloblastic Leukem
Location: Green Bay, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Green Bay, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Green Bay, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Green Bay, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Green Bay, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Green Bay, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Marinette, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Oconto Falls, Wisconsin
- Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
Conditions: Chronic Myelomonocytic Leukemia - de Novo Myelodysplastic Syndromes - Previously Treated Myelodysplastic Syndromes - Refractory Anemia With Excess Blasts - Secondary Myelodysplastic Syndromes
Location: Sturgeon Bay, Wisconsin
|